title: Antiplatelet agents: current drugs and future trends.
abstract: Antiplatelet drugs in clinical use are discussed in terms of their mechanisms of action and the relevancy of that to the physiology of platelets and the pathophysiology of arterial thrombosis. Current clinical usage is outlined in detail for each drug. Experimental antiplatelet drugs also are discussed.
authors.affiliation: Hines Veteran's Affairs Hospital, Hines, IL 60141, USA. hlmehd64@aol.com
authors.forename: Harry L
authors.initials: HL
authors.lastname: Messmore
authors.forename: Walter P
authors.initials: WP
authors.lastname: Jeske
authors.forename: William
authors.initials: W
authors.lastname: Wehrmacher
authors.forename: Erwin
authors.initials: E
authors.lastname: Coyne
authors.forename: Sohrab
authors.initials: S
authors.lastname: Mobarhan
authors.forename: Leslie
authors.initials: L
authors.lastname: Cho
authors.forename: Fred S
authors.initials: FS
authors.lastname: Leya
authors.forename: John F
authors.initials: JF
authors.lastname: Moran
mesh_terms: D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000188:drug therapy; D005544:Forecasting; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors